The IPOX^® Update archive

Jan2026

31 January 2026

The IPOX^® Update 1/31/2026

SpaceX dominates headlines with a potential $1.5 trillion IPO and xAI merger. Defense firm York Space Systems debuts at $4.75 billion, with IPOX^® Associate Lukas Muehlbauer noting the sector’s strength. Muehlbauer also analyzes AI infrastructure play Forgent Power and biotech Eikon Therapeutics. IPOX^® VP Kat Liu discusses tariff risks for Bob's Discount Furniture, while IPOX^® CEO Josef Schuster warns against celebrity-backed listings. Elsewhere, software firm Anaplan preps a return, and JD.com ’s property arm files in Hong Kong.

Read edition →

Jan2026

24 January 2026

The IPOX^® Update 1/24/2026

SpaceX accelerates blockbuster IPO plans by lining up four Wall Street banks, while construction tech firm EquipmentShare hits a $7.2 billion valuation in its Nasdaq debut. IPOX^® Associate Lukas Muehlbauer analyzes the deal and crypto custodian BitGo’s volatile start as a 2026 bellwether. The U.S. pipeline grows with filings from prime broker Clear Street and Brazilian fintech Agibank, plus potential moves by Jersey Mike’s and Ledger. Globally, European tank maker KNDS prepares a €25 billion listing, and Alibaba’s chip unit explores a spin-off.

Read edition →

Jan2026

17 January 2026

The IPOX^® Update 1/17/2026

The U.S. IPO pipeline accelerates as construction tech firm EquipmentShare targets a $6.4 billion valuation, with IPOX^® VP Kat Liu highlighting its "narrative premium." Crypto custodian BitGo eyes a $2 billion debut, drawing commentary from IPOX^® CEO Josef Schuster and Associate Lukas Muehlbauer on market selectivity. Brazilian fintech Agibank files for a $1 billion listing. Globally, Czech defense giant CSG launches a massive €30 billion IPO, while Chinese chipmaker Montage Technology preps a $22 billion Hong Kong debut.

Read edition →

Jan2026

10 January 2026

The IPOX^® Update 1/10/2026

Aktis Oncology surges 24% in the first major biotech IPO of 2026, with IPOX^® Associate Lukas Muehlbauer highlighting its strategic backing. The U.S. pipeline accelerates as chat platform Discord and fitness app Strava confidentially file for listings, while President Trump weighs a massive Fannie Mae and Freddie Mac public offering. Additionally, Brazilian fintech PicPay files for a $500 million Nasdaq debut, signaling a robust return of large-cap issuers to the market.

Read edition →

Jan2026

2 January 2026

The IPOX^® Update 1/2/2026

In Europe, Octopus Energy spins off its tech arm Kraken at an $8.7 billion valuation to prepare for a future listing. Asia sees a surge in activity as VinFast affiliate GSM targets a massive $20 billion international IPO. Meanwhile, Chinese tech listings accelerate with Alibaba-backed AI unicorn MiniMax launching its $600 million Hong Kong debut and Baidu’s chip unit Kunlunxin filing for a spin-off, while regulators ease rules for rocket firms like LandSpace.

Read edition →

Dec2025

26 December 2025

The IPOX^® Update 12/26/2025

Bill Ackman proposes a unique SpaceX merger, while Medtronic’s MiniMed and fleet AI firm Motive Technologies file for U.S. debuts. SoftBank delays its PayPay IPO to prioritize OpenAI funding, while China’s LandSpace and pet care group Ringpai advance listing plans. In Europe, Visma expands its syndicate for a blockbuster London deal, and Aegea files to break Brazil’s four-year IPO drought, as Seven & i accelerates its U.S. turnaround.

Read edition →

Dec2025

20 December 2025

The IPOX^® Update 12/20/2025

OpenAI and SpaceX headline the 2026 pipeline with potential $1 trillion+ valuations, fueling Nasdaq’s optimistic outlook. Andersen Group surged 31% in its debut, with IPOX^® VP Kat Liu crediting strong brand recognition. In Europe, Elliott preps a London listing for Waterstones and Barnes & Noble. Meanwhile, a wave of Chinese AI and chip firms targets Hong Kong, while Saudi markets cool following EFSIM’s cancellation and CloudKitchens’ delay.

Read edition →

Dec2025

13 December 2025

The IPOX^® Update 12/15/2025

SpaceX dominates headlines with plans for a record-breaking IPO targeting a $1.5 trillion valuation. IPOX^® CEO Josef Schuster weighs in on the blockbuster pipeline, while IPOX^® Associate Lukas Muehlbauer analyzes Wealthfront’s debut and EquipmentShare’s filing. Tax firm Andersen targets a $1.75 billion deal, Michael Burry eyes a Fannie Mae re-listing, and Magnum completes its spin-off, while Hong Kong sees crypto and robotics activity.

Read edition →

Dec2025

6 December 2025

The IPOX^® Update 12/06/2025

AI takes the lead as Anthropic preps for a potential 2026 IPO and Baidu’s Kunlunxin eyes a Hong Kong listing. IPOX^® Associate Lukas Muehlbauer comments on Wealthfront’s $2.05 billion target amid mixed sentiment. Elsewhere, Unilever’s ice cream unit advances spin-off plans, Barrick Gold explores a North American IPO, and Morgan Stanley predicts a dealmaking surge, even as travel unicorn Klook delays its U.S. debut.

Read edition →